AMCP letter to Congressional Leadership asking for the inclusion of 42 CFR Part 2 provisions and Medicare fraud, waste and abuse protections in a final opioid conference report
Press Release: Opioid Prescribing in Georgia Medicaid Program: Potentially Inappropriate Practices are Increasing, According to a Study in JMCP
Letter in support of state legislation on mandatory e-prescribing of controlled substances.
Press Release: AMCP Launches New Addiction Advisory Group (AAG) to Address Opioid Crisis Through Promotion of Best Practices, Innovative Care Models and Benefit Designs
AMCP comments supporting state legislation allowing insurers access to the PDMP.
AMCP webinar that discussed current ASAM guidelines and other clinical guidance regarding MAT.
AMCP webinar that discussed current ASAM guidelines and other clinical guidance regarding MAT.
AMCP webinar that reviewed the AMCP Addiction Treatment Advisory Group (ATAG) recommendations to improve access to medication-assisted treatment and naloxone.
AMCP webinar that reviewed the AMCP Addiction Treatment Advisory Group (ATAG) recommendations to improve access to medication-assisted treatment and naloxone.
Press Release: Improvements to opioid prescribing, increasing the use of naloxone to reverse opioid overdose and expanding the use of medication-assisted treatment (MAT) for opioid-use disorders were among the many suggestions to come out of the Academy of Managed Care Pharmacy (AMCP) Foundation 6th Annual Research Symposium, “Balancing Access and Use of Opioid Therapy.”
AMCP webinar that provided a legal and regulatory overview of state-level access to opioid overdose antidotes and discussing best practices for educating patients and providers on the prevention of opioid overdose.
AMCP webinar that provided a legal and regulatory overview of state-level access to opioid overdose antidotes and discussing best practices for educating patients and providers on the prevention of opioid overdose.
